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Abstract
Background:  Renal cell carcinoma is associated with a wide spectrum of para-neoplastic
syndromes, which may be precursors of primary or recurrent disease. Non-metastatic hepatic
dysfunction in patients suffering from renal cell carcinoma is known as Stauffer's syndrome. It is
associated with the production of cytokines by the tumour, and several biochemical abnormalities,
including elevated serum alkaline phosphatase.
Case presentation: We describe a 36-year-old woman presenting with various non-specific,
systemic disease manifestations, and elevated liver enzymes due to cholestasis as the main
laboratory abnormality. Imaging studies showed a solid mass in the left kidney, which, after surgical
excision, was identified as renal cell carcinoma. No metastasis was found.
Conclusion: Stauffer syndrome may precede other manifestations of renal cell carcinoma. In case
of unexplained abnormal liver function, particularly in presence of systemic symptoms, underlying
renal cell carcinoma should be excluded by focused investigations.
Background
Renal cell carcinoma (RCC) is associated with an up to
20% prevalence of para-neoplastic syndromes. Since a
para-neoplastic manifestation may be the initial clinical
presentation in a considerable proportion of patients, its
recognition facilitates the early diagnosis of RCC [1-3]. In
1961, Stauffer described abnormal liver function tests,
hepato-splenomegaly, histologic changes consistent with
non-specific hepatitis, and a reversal of these abnormali-
ties after nephrectomy, in patients suffering from RCC [4].
Hepatic dysfunction, in absence of liver metastases, occurs
in 10 to 15% of RCC, attributed to the production of
cytokines from the tumour, including interleukin-6 [5,6].
It is associated with fever, weight loss and an unfavoura-
ble prognosis [7].
We report a case of a young woman presenting with non-
specific constitutional symptoms and a notable isolated
elevation of cholestatic liver enzymes.
Case presentation
A 36-year-old housewife who lived with her husband and
4 children in a small town, was admitted to the hospital
because of a 6-month history of anorexia, 20-kg body
weight loss, fatigue and malaise. A diagnosis of hyperthy-
roidism due to Graves' disease had been made 10 months
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earlier, on the basis of consistent clinical manifestations,
elevated thyroid hormones, suppressed concentrations of
TSH and positive thyroid peroxidase antibodies, and the
patient had since been treated with methimazole. She had
a history of idiopathic epilepsy treated with phenytoin
since the age of 19 years. She was also treated with panto-
prazole for dyspepsia and ferrous sulfate for iron defi-
ciency anemia attributed to menstruations. There was no
family history of autoimmune disease or cancer. None of
her close contacts had been ill. She had smoked 20 ciga-
rettes daily for 15 years, and did not consume alcohol or
use illegal drugs. She had not travelled abroad recently.
On physical examination, the patient appeared chroni-
cally ill, weighed 38 kg, was 160 cm tall, with a body mass
index of 14.8. Her temperature was 37.8°C, blood pres-
sure 100/60 mmHg, and heart rate 100 bpm. The thyroid
gland was diffusely enlarged, without palpable nodules,
and was non-tender. The remainder of the examination
was normal.
The most prominent laboratory abnormality was elevated
serum liver enzymes, consistent with cholestasis, includ-
ing alkaline phosphatase at 396 U/l (normal < 129 U/l)
and γ-glutamyltransferase at 654 U/l (normal < 61 U/l).
Serum bilirubin and aminotransferases were normal.
Hemoglobin was 11.0 g/dl, white cell 8,500/mm3, with a
normal differential count, platelets 438,000/mm3, mean
corpuscular volume 79 μm3, erythrocyte sedimentation
rate 125 mm/h, C-reactive protein, 25 mg/dl (normal <
0.5 mg/dl); serum ferritin 363 ng/ml, total serum protein
8.1 g/dl, and albumin 3 g/dl. A polyclonal gammopathy
was observed on serum protein electrophoresis. The
serum TSH concentration was < 0.004 μU/ml, while the
serum free thyroxine and triiodothyronine concentrations
were within the normal range. Immunologic investiga-
tions revealed the absence of rheumatoid factor and anti-
nuclear, antineutrophil cytoplasmic and
antimitochondrial antibodies. The urinalysis showed no
hematuria or pyuria, blood and urine cultures were sterile,
cytologic examination of the urine showed no malignant
cells and the tuberculin skin test was negative.
On ultrasound of the abdomen a 7.8-cm in diameter solid
mass was present in the mid portion of the left kidney. No
other organ abnormality was observed. An abdominal
computed tomography (CT) scan (figure 1), obtained
after oral and intravenous administration of contrast
material, confirmed the results of ultrasonography, reveal-
ing a highly heterogenous renal mass, which contained
multiple necrotic areas and zones of solid enhancement.
The left renal vein and contralateral kidney were normal.
There was no abdominal lymphadenopathy or liver
metastasis. Distant metastases were absent on chest CT
and radionuclide bone scans.
After the left kidney was surgically excised, a 6.8 × 6.5 ×
5.7 cm tumour was found within the central parenchyma,
which, on gross examination, dislodged but did not
invade the renal pelvis and calyces. A Fuhrman nuclear
grade 3 [8] clear-cell, renal-cell carcinoma was present on
histological examination, invading the pelvi-caliceal sys-
tem, (though leaving intact the overlying urothelium), the
renal capsule and the perirenal fat. The surgical margins
were free of tumour. The patient made an uneventful post-
operative recovery.
At 1 year of follow-up, the patient is afebrile and has
regained weight. Her appetite has returned and she feels
well. The serum concentrations of cholestatic liver
enzymes have returned to normal.
Discussion
The differential diagnosis of this prolonged illness, char-
acterized by systemic symptoms and a rapid and pro-
found involuntary weight loss, was wide. In this young
patient, diabetes mellitus, hyperthyroidism, psychiatric
disturbances, infection (particularly with HIV) and drug
abuse were the most likely disease entities. Her anorexia
argued against diabetes, hyperthyroidism and malabsorp-
tion syndromes. The presence of fever and malaise sug-
gested the presence of an infectious, neoplastic or
inflammatory disease. The latter was further suggested by
thrombocytosis, markedly accelerated erythrocyte sedi-
mentation rate, elevated C-reactive protein and ferritin,
and polyclonal hyperglobulinemia. The normal concen-
trations of free thyroxine and triiodothyronine confirmed
that hyperthyroidism was being successfully controlled.
While TSH was nearly undetectable, the production of
Presence of a left renal mass on abdominal computed tomog- raphy scan Figure 1
Presence of a left renal mass on abdominal com-
puted tomography scan.Cases Journal 2009, 2:49 http://www.casesjournal.com/content/2/1/49
Page 3 of 4
(page number not for citation purposes)
TSH often remains suppressed for several months after
onset of therapy, thus is not a sensitive indicator of
response to treatment.
The markedly elevated alkaline phosphatase and γ-
glutamyltransferase in absence of hypertransaminasemia,
was the main laboratory abnormality. This biochemical
pattern was consistent with intra- or extrahepatic cholesta-
sis, though the serum bilirubin concentration was nor-
mal. We were concerned that our patient might have
developed phenytoin hepatotoxicity. Asymptomatic ele-
vation of cholestatic enzymes has been observed in a siz-
able proportion of patients treated with phenytoin on the
long term. However, liver injury caused by phenytoin is
manifest as an elevation of both alkaline phosphatase and
alanine aminotransferases concentrations [9]. Thyrotoxi-
cosis, another cause of elevated liver enzymes, was
excluded by the normal hormonal measurements. Finally,
primary sclerosing cholangitis and primary biliary cirrho-
sis were highly unlikely diagnoses in view of the negative
immunologic investigations.
Most surprisingly, upper abdomen ultrasonography per-
formed in search of intrahepatic or extrahepatic bile duct
dilatation revealed the existence of a renal tumour and no
abnormality of the liver and biliary tree. Anicteric, intra-
hepatic cholestasis is the main form of Stauffer's syn-
drome, while jaundice is uncommon [10,11]. As it may be
the only manifestation of an otherwise occult RCC, its
detection should prompt appropriate diagnostic efforts to
enable an early diagnosis [12]. The postoperative course
can also be predicted by monitoring of the liver function
tests. Since nephrectomy normalizes the liver enzymes,
their recurrent elevation is a sign of relapsing local or met-
astatic disease [13].
RCC is characterized by varied and sometimes obscure
manifestations and therefore constitutes a paradigm of
latent disease [14]. Because of the multiple initial signs
and symptoms, most of which are systemic and non-spe-
cific, it has become known as the "internist's tumour". The
classical triad of hematuria, abdominal pain and palpable
flank or abdominal mass occurs in < 10% of patients [15].
Our patient had none of these manifestations, not even
microscopic haematuria. This case illustrates the impor-
tance of being familiar with Stauffer's syndrome, with a
view to make an early diagnosis and offer an operative
cure of RCC.
Conclusion
In all cases of unexplained liver abnormalities, particu-
larly when combined with systemic disease manifesta-
tions, non-metastatic hepatic dysfunction caused by RCC
(Stauffer's syndrome) should be suspected and appropri-
ate imaging studies performed, to make an early diagnosis
and increase the likelihood of operative success. Clini-
cians should be aware of RCC's propensity to present as a
broad spectrum of non-renal, instead of typical, manifes-
tations.
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